Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Dec;22(6):627–632. doi: 10.1111/j.1365-2125.1986.tb02949.x

Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.

E Wong, R M Barr, F M Cunningham, K Mistry, P M Woollard, A I Mallet, M W Greaves
PMCID: PMC1401212  PMID: 3032226

Abstract

Topical clobetasol propionate or vehicle ointment was applied daily for 3 days to psoriatic plaques on eight patients. Skin chamber exudates from untreated, steroid and vehicle treated lesions were assayed for arachidonic acid (AA), leukotriene B4 (LTB4), prostaglandin E2 (PGE2) and 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) before, and at 24 h and 72 h after treatment. Significant reductions in AA and LTB4 were observed at 72 h in steroid treated lesions. The reduction in 12-HETE levels observed after steroid treatment was not statistically significant. PGE2 levels in lesional psoriatic skin were unaltered. The reduction of AA, and LTB4 was associated with clinical improvement of psoriasis.

Full text

PDF
627

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barr R. M., Brain S., Camp R. D., Cilliers J., Greaves M. W., Mallet A. I., Misch K. Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol. 1984 Jul;111(1):23–28. doi: 10.1111/j.1365-2133.1984.tb04012.x. [DOI] [PubMed] [Google Scholar]
  2. Barr R. M., Wong E., Mallet A. I., Olins L. A., Greaves M. W. The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins. 1984 Jul;28(1):57–65. doi: 10.1016/0090-6980(84)90113-8. [DOI] [PubMed] [Google Scholar]
  3. Black A. K., Greaves M. W., Hensby C. N., Plummer N. A., Warin A. P. The effects of indomethacin on arachidonic acid and prostaglandins e2 and f2alpha levels in human skin 24 h after u.v.B and u.v.C irradiation. Br J Clin Pharmacol. 1978 Sep;6(3):261–266. doi: 10.1111/j.1365-2125.1978.tb04595.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  5. Brain S., Camp R., Dowd P., Black A. K., Greaves M. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol. 1984 Jul;83(1):70–73. doi: 10.1111/1523-1747.ep12261712. [DOI] [PubMed] [Google Scholar]
  6. Camp R. D., Mallet A. I., Woollard P. M., Brain S. D., Black A. K., Greaves M. W. The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins. 1983 Sep;26(3):431–447. doi: 10.1016/0090-6980(83)90178-8. [DOI] [PubMed] [Google Scholar]
  7. Camp R., Jones R. R., Brain S., Woollard P., Greaves M. Production of intraepidermal microabscesses by topical application of leukotriene B4. J Invest Dermatol. 1984 Feb;82(2):202–204. doi: 10.1111/1523-1747.ep12259945. [DOI] [PubMed] [Google Scholar]
  8. Dowd P. M., Kobza Black A., Woollard P. M., Camp R. D., Greaves M. W. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE). J Invest Dermatol. 1985 Jun;84(6):537–541. doi: 10.1111/1523-1747.ep12273537. [DOI] [PubMed] [Google Scholar]
  9. Hammarström S., Hamberg M., Duell E. A., Stawiski M. A., Anderson T. F., Voorhees J. J. Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids. Science. 1977 Sep 2;197(4307):994–996. doi: 10.1126/science.887938. [DOI] [PubMed] [Google Scholar]
  10. Hammarström S., Hamberg M., Samuelsson B., Duell E. A., Stawiski M., Voorhees J. J. Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5130–5134. doi: 10.1073/pnas.72.12.5130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hawk J. L., Black A. K., Jaenicke K. F., Barr R. M., Soter N. A., Mallett A. I., Gilchrest B. A., Hensby C. N., Parrish J. A., Greaves M. W. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol. 1983 Jun;80(6):496–499. doi: 10.1111/1523-1747.ep12535038. [DOI] [PubMed] [Google Scholar]
  12. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hirata F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem. 1981 Aug 10;256(15):7730–7733. [PubMed] [Google Scholar]
  14. Jablonska S., Chowaniec O., Beutner E. H., Maciejowska E., Jarzabek-Chorzelska M., Rzesa G. Stripping of the stratum corneum in patients with psoriasis: production of prepinpoint papules and psoriatic lesions. Arch Dermatol. 1982 Sep;118(9):652–657. [PubMed] [Google Scholar]
  15. Klickstein L. B., Shapleigh C., Goetzl E. J. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest. 1980 Nov;66(5):1166–1170. doi: 10.1172/JCI109947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kobza Black A., Greaves M. W., Hensby C. N. The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation. Br J Clin Pharmacol. 1982 Sep;14(3):391–394. doi: 10.1111/j.1365-2125.1982.tb01996.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science. 1984 Sep 21;225(4668):1365–1370. doi: 10.1126/science.6147898. [DOI] [PubMed] [Google Scholar]
  18. Norris J. F., Ilderton E., Yardley H. J., Summerly R., Forster S. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action. Br J Dermatol. 1984 Jul;111 (Suppl 27):195–203. doi: 10.1111/j.1365-2133.1984.tb15605.x. [DOI] [PubMed] [Google Scholar]
  19. Parente L., Di Rosea M., Flower R. J., Ghiara P., Meli R., Persico P., Salmon J. A., Wood J. N. Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol. 1984 Mar 23;99(2-3):233–239. doi: 10.1016/0014-2999(84)90246-2. [DOI] [PubMed] [Google Scholar]
  20. Smith M. J., Walker J. R. The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis. Br J Pharmacol. 1980 Jul;69(3):473–478. doi: 10.1111/j.1476-5381.1980.tb07037.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wong E., Barr R. M., Brain S. D., Greaves M. W., Olins L. A., Mallet A. I. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin. Br J Clin Pharmacol. 1984 Oct;18(4):523–527. doi: 10.1111/j.1365-2125.1984.tb02499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Woollard P. M., Mallet A. I. Lipoxygenase products. A novel gas chromatographic-mass spectrometric assay for monohydroxy fatty acids. J Chromatogr. 1984 Mar 9;306:1–21. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES